Shelia M. Violette insider trades: Q32 Bio (QTTB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shelia reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | QTTB | ↓ Sell | 917 | $8.32 | $8K | Direct | Oct 14, 2026 (8d) |
| Aug 25, 2026 | QTTB | ↓ Sell | 2,798 | $16.56 | $46K | Direct | Aug 27, 2026 (2d) |
| Feb 25, 2026 | QTTB | ↓ Sell | 2,815 | $4.51 | $13K | Direct | Feb 27, 2026 (2d) |
| Aug 26, 2025 | QTTB | ↓ Sell | 2,990 | $1.80 | $5K | Direct | Aug 28, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other QTTB insiders
Open-market trades in the last 12 months
About Shelia M. Violette's insider trades
Shelia M. Violette is Chief Scientific Officer at Q32 Bio (QTTB). Since Aug 26, 2025, Shelia has reported no open-market purchases and 4 sales worth $72K on SEC Form 4. In the last 12 months: 3 sales ($67K).
Their filings also include grants and awards (4 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every QTTB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.